Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remifentanil Requirement for Acceptable Intubating Condition With Two Dose Ketamine Without Neuromuscular Blocking Agent in Children

NCT02655380 is registered in ClinicalTrials.gov with Ajou University School of Medicine as lead sponsor.

NCT NCT02655380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02655380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remifentanil Requirement for Acceptable Intubating Condition With Two Dose Ketamine Without Neuromuscular Blocking Agent in Children
Lead sponsor
Ajou University School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
June 19, 2017
Completion date
April 16, 2018
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intubating condition